New Key Statistics Module, Z-Score and F-Score
NAS:SUPN Key Ratios
Market Cap $ M | 1,604.28 |
Enterprise Value $ M | 1,442.93 |
P/E(ttm) | -- |
PE Ratio without NRI | 110.19 |
Forward PE Ratio | -- |
Price/Book | 1.74 |
Price/Sales | 2.73 |
Price/Free Cash Flow | 15.56 |
Price/Owner Earnings | 32.95 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 607.00 |
EPS (TTM) $ | -0.003 |
Beneish M-Score | -2.76 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -12.10 |
y-y EBITDA Growth Rate % | -34.80 |
EV-to-EBIT | 278.34 |
EV-to-EBITDA | 16.02 |
PEG | -- |
Shares Outstanding M | 54.73 |
Net Margin (%) | 0.22 |
Operating Margin % | 2.21 |
Pre-tax Margin (%) | 0.46 |
Quick Ratio | 1.43 |
Current Ratio | 1.70 |
ROA % (ttm) | 0.09 |
ROE % (ttm) | 0.14 |
ROIC % (ttm) | 0.57 |
Dividend Yield % | -- |
Altman Z-Score | 4.00 |
SUPN Number of Guru Trades
SUPN Volume of Guru Trades
Gurus Latest Trades with NAS:SUPN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SUPN is held by these investors
Total 4
Supernus Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:SUPN
Total 0- 1